These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3641542)

  • 1. Poor seroconversion rate after hepatitis B vaccination in high-risk institutionalized mentally retarded patients.
    Cooper BW; Klimek JJ; Upadhyaya A; Devine S
    Am J Infect Control; 1986 Oct; 14(5):204-8. PubMed ID: 3641542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B carriers in a centre for the mentally retarded in Finland and immunogenicity of hepatitis B vaccine.
    Mölsä PK
    J Ment Defic Res; 1990 Aug; 34 ( Pt 4)():379-83. PubMed ID: 2144593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B vaccination in Down's syndrome and other mentally retarded patients.
    Heijtink RA; De Jong P; Schalm SW; Masurel N
    Hepatology; 1984; 4(4):611-4. PubMed ID: 6235163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of immunity to hepatitis B vaccination in institutionalized mentally retarded patients.
    Torre D; Broggini M; Botta V; Sampietro C
    Vaccine; 1989 Apr; 7(2):102-3. PubMed ID: 2526418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term observation of the effect of intradermal hepatitis B vaccination on mentally retarded patients.
    Hayashi J; Noguchi A; Nakashima K; Morofuji M; Kashiwagi S
    Eur J Epidemiol; 1991 Nov; 7(6):649-53. PubMed ID: 1838338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
    Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody to hepatitis A antigen in institutionalized mentally retarded patients.
    Szmuness W; Purcell RH; Dienstag JL; Stevens CE
    JAMA; 1977 Apr; 237(16):1702-5. PubMed ID: 139479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients.
    Van Damme P; Vranckx R; Safary A; André FE; Meheus A
    Am J Med; 1989 Sep; 87(3A):26S-29S. PubMed ID: 2528294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis B infection among residents of an institution for the mentally retarded.
    Chaudhary RK; Perry E; Cleary TE
    Am J Epidemiol; 1977 Feb; 105(2):123-6. PubMed ID: 138362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term immunogenicity of standard and accelerated hepatitis B virus vaccination schedules in healthy adults: a comparative field study in China.
    Zhang X; Wang J; Chen X; Yu M; Yu S; Sun Y; Duan J; Sun H; Yuan P
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30201691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection.
    Navarro JF; Teruel JL; Mateos ML; Marcen R; Ortuno J
    Am J Nephrol; 1996; 16(2):95-7. PubMed ID: 8919223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suitable hepatitis B vaccine for adult immunization in China.
    Yang L; Yao J; Li J; Chen Y; Jiang ZG; Ren JJ; Xu KJ; Ruan B; Yang SG; Wang B; Xie TS; Li Q
    Immunol Res; 2016 Feb; 64(1):242-50. PubMed ID: 26645972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers.
    Lo KJ; Lee SD; Tsai YT; Wu TC; Chan CY; Chen GH; Yeh CL
    Hepatology; 1988; 8(6):1647-50. PubMed ID: 3192179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3.
    Krairittichai U; Sethakarun S
    J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S1-7. PubMed ID: 29926711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccination against hepatitis B possibly indicated for elderly institutionalized mentally handicapped persons with isolated anti-HBc positivity of the prevaccination serum].
    Vrijmoeth P; Heijtink RA; Schreuder H; Kroes AC
    Ned Tijdschr Geneeskd; 1997 Aug; 141(35):1694-7. PubMed ID: 9543786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B in a Belgian institution for mentally retarded patients: an epidemiological study.
    Devuyst O; Maesen-Collard Y
    Acta Gastroenterol Belg; 1991; 54(1):12-8. PubMed ID: 2058345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B vaccination for staff in institutions for the mentally handicapped.
    Jayaratnam R
    Public Health; 1988 May; 102(3):257-62. PubMed ID: 2968611
    [No Abstract]   [Full Text] [Related]  

  • 20. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.